NCT02758964View on ClinicalTrials.gov

Evaluation of Cerebral Thrombembolism After TAVR

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Aortic Valve StenosisTranscatheter Aortic Valve ReplacementIntracranial Embolism
Interventions
OTHER

MRI, neurocognitive Testing

A cerebral MRI and neurocognitive testing will be performed before TAVR, before hospital discharge and after 3 months

Trial Locations (2)

10117

Charité - Universitätsmedizin Berlin, Campus Mitte, Berlin

12203

Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Charite University, Berlin, Germany

OTHER